Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$609.69 USD

609.69
409,912

+11.66 (1.95%)

Updated Aug 6, 2024 11:58 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

TMO vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

TMO vs. SONVY: Which Stock Is the Better Value Option?

Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $555.19 in the latest trading session, marking a +0.16% move from the prior day.

Strength Seen in Inogen (INGN): Can Its 5.0% Jump Turn into More Strength?

by Zacks Equity Research

Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $547.34, marking a -1.75% move from the previous day.

Thermo Fisher (TMO) Introduces iCAP RQplus ICP-MS Analyzer

by Zacks Equity Research

Thermo Fisher's (TMO) new analyzer streamlines everyday analyses in environmental, food, pharmaceutical and industrial testing laboratories.

Thermo Fisher (TMO) Unveils New Line of Low-Flow HPLC Columns

by Zacks Equity Research

Thermo Fisher's (TMO) newest addition of a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples.

TMO or IDXX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TMO vs. IDXX: Which Stock Is the Better Value Option?

BD (BDX) Boosts Molecular Diagnostics Portfolio With New Tests

by Zacks Equity Research

Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.

Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how IPSEN (IPSEY) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $559.44, marking a +1.95% move from the previous day.

Why Is Thermo Fisher (TMO) Down 6.5% Since Last Earnings Report?

by Zacks Equity Research

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Humana (HUM) Exits Business Line to Focus More on Core Units

by Zacks Equity Research

Humana (HUM) will depart from the Employer Group Commercial Medical Products business so that it can invest more funds to grow its core Insurance business lines.

Zacks.com featured highlights include Everest Re Group, Thermo Fisher Scientific and Sony Group

by Zacks Equity Research

Everest Re Group, Thermo Fisher Scientific and Sony Group are part of the Zacks Screen of the Week article.

Swayta Shah headshot

3 Stocks With Sales Growth to Buy Amid Persistent Inflation

by Swayta Shah

Sales growth is vital for the survival of a business, even during an economic slowdown. Everest Re (RE), Thermo Fisher (TMO) and Sony Group (SONY) are recording top-line growth.

TMO vs. IDXX: Which Stock Is the Better Value Option?

by Zacks Equity Research

TMO vs. IDXX: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser

by Zacks Equity Research

Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser are part of the Zacks top Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Merck, Thermo Fisher Scientific & American Express

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Thermo Fisher Scientific Inc. (TMO) and American Express Company (AXP).

Select Medical (SEM) Enters JV to Boost New Jersey Healthcare

by Zacks Equity Research

Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.

Thermo Fisher (TMO) Rides on Strong End Markets, New Launches

by Zacks Equity Research

Thermo Fisher's (TMO) newly-launched Gibco CTS DynaCellect Magnetic Separation System is helping customers advance their cell and gene therapy programs.

Encompass Health's (EHC) Shares Up 3% on Q4 Earnings Beat

by Zacks Equity Research

Encompass Health's (EHC) fourth-quarter results reflect growing patient volumes and reimbursement rates. Management expects 2023 adjusted EPS within $2.87-$3.16, higher than $2.85 in 2022.

Catalent (CTLT) Surges on Rumors of Acquisition by Danaher

by Zacks Equity Research

Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.

Cigna (CI) Q4 Earnings Top on U.S. Commercial Unit, Dividend Up

by Zacks Equity Research

Cigna's (CI) fourth-quarter results reflect the strong contribution from the Evernorth segment. Management sanctions a 10% increase in the quarterly dividend.

Thermo Fisher (TMO) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Thermo Fisher (TMO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Company News for Feb 2, 2023

by Zacks Equity Research

Companies in The News Are: ALGN, TMO, ATKR, WRK.